BioSpace News Archive

Arrakis Therapeutics, a biopharmaceutical company pioneering the discovery of a new class of small-molecule medicines that directly target RNA, today announced that Elizabeth Radcliffe has joined as the company’s Vice President of Finance and Strategy.

Personalis, Inc. (Nasdaq:PSNL), a leader in advanced genomics for cancer, today announced a collaboration with Merck KGaA, Darmstadt, Germany, a leading science and technology company, to investigate novel biomarkers of response and mechanisms of resistance to cancer therapies.

Hemostemix Inc., a biotechnology company developing and commercializing blood-derived stem cell therapies for unmet medical conditions, announces that the Company and Kingsman Scientific Management Inc. have agreed to the early termination of the KSM management services agreement dated April 19, 2019 (the “Management Agreement”), with such termination effective October 31, 2019.

binx health, the pioneer in anywhere, anytime testing for women’s health, today announced that Jeffrey Luber, president and CEO is scheduled to present on Thursday, November 21, 2019 at 11:00 a.m. ET at the Canaccord Genuity Medical Technology & Diagnostics Forum in New York City

NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the PainShield® Surface Acoustic Wave (SAW) Portable Ultra Sonic therapeutic device, today provided a business update for the third quarter ended September 30, 2019.

Astarte Medical, the only precision medicine company using software and predictive analytics to improve preterm infant outcomes, today announced that it has closed an additional $3.5 million in financing to support the commercialization and adoption of its NICUtrition Suite

Since its start in 1991, the Wine Country Tour de Cure has become a destination, marquis event for the Association annually raising millions of dollars for diabetes research, education and advocacy initiatives, including its #CountMeIn campaign.

Genesis Drug Discovery & Development (GD3), a member of Genesis Biotechnology Group, has acquired New England Discovery Partners (NEDP), a Contract Research Organization (CRO) specializing in synthetic and medicinal chemistry.

The National Institute for Diabetes and Digestive and Kidney Diseases (NIDDK) division of the National Institutes of Health (NIH) has awarded a Phase II Small Business Innovative Research (SBIR) grant for $1,487,764 to Enable Biosciences to develop lab techniques to test samples collected at home for type 1 diabetes risk.

Digestive health startup Vivante Health, creators of the GIThrive all-in-one digital health solution for gut health and disease, announced Jonathan Fox has joined the company’s Board of Advisors.